Abstract
Active surveillance to identify asymptomatic carriers of carbapenemresistant Enterobacteriaceae (CRE) is a recommended strategy for CRE control in healthcare facilities. Active surveillance using stool specimens tested for Clostridium difficile is a relatively low-cost strategy to detect CRE carriers. Further evaluation of this and other risk factor-based active surveillance strategies is warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 82-84 |
| Number of pages | 3 |
| Journal | Infection Control and Hospital Epidemiology |
| Volume | 35 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2014 |